Central regions | Finance, business | Technology & innovation

HIV drug development under way, gets Skolkovo support

30 May '16
Viriom, a biomedical developer and asset of the ChemRar High Tech Center in Khimki outside Moscow, has been working on Russia’s first HIV solution which is expected to go beyond import substitution—an across-the-board goal the Russians have been pursuing in many sectors since the current crisis and western sanctions began—and offer “high potential for international commercialization.”

The new drug candidate’s safety, high efficacy and tolerance are said to have been proven during five rounds of phases 1 and 2 clinical trial testing. Phase 3 of clinical trials is currently under way in 18 AIDS prevention centers across Russia.

The Skolkovo Foundation, which is managing Russia’s most widely touted innovation hub just outside Moscow, earlier this year approved a new $2.2m grant for the next stage of the effort.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content
 

Feature stories

7 Dec '16
In spite of all current problems and adverse external...
2 Nov '16
Search (News archive - 21023)
Advertising
ARCCoM
Advertising
RBTH_Kendrick
Advertising
Hi-tech Technopark Association of Russia
Advertising
ITMO University

Latest News

18 Jan '17
Russia fell 14 spots to #26 in the latest Bloomberg...
17 Jan '17
Experiments conducted by Siberian scientists show...
13 Jan '17

Most read stories from last week

17 Jan '17
Experiments conducted by Siberian scientists show...
18 Jan '17
Russia fell 14 spots to #26 in the latest Bloomberg...